USPM is a biopharma with a new cancer drug undergoing FDA IND research application that is supported by 3 patents with 20-year life protection. Originally focused on breast cancer, colorectal cancer, prostate cancer, uterine cancer and Ovarian cancer, research indicates the drug can be effective against all cancers: solid tumors, blood-borne tumors and metastatic tumors.
Ready to Ask For Funding for your company?
Post a Funding Request